Shijiazhuang, China

Kai Shi

This inventor holds 1 USPTO granted patent. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Shi. Retrieved from https://idiyas.com/inventor/kai-shi-vb7s8qg1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Kai Shi

Introduction

Kai Shi is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical technology. His work focuses on improving the solubility and druggability of compounds, which is crucial for effective medication development.

Latest Patents

Kai Shi holds a patent for a "Salt of arylaminoquinazoline-containing compound, and preparation method therefor and use thereof." This patent describes a salt of an arylaminoquinazoline-containing compound, which exhibits improved crystallinity and significantly enhanced water solubility compared to its free form. The stability of the salt form and crystal form makes it a promising candidate for pharmaceutical applications.

Career Highlights

Kai Shi is currently employed at Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His innovative work has led to advancements in drug formulation and delivery systems. He has demonstrated a commitment to enhancing the effectiveness of pharmaceutical compounds through his research and development efforts.

Collaborations

Some of his notable coworkers include Fugang Zhou and Yuxia He. Their collaborative efforts contribute to the ongoing success and innovation within their organization.

Conclusion

Kai Shi's contributions to pharmaceutical technology exemplify the importance of innovation in drug development. His patent reflects a significant advancement in the field, showcasing his dedication to improving medication efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…